| Model Number |
6900PTFX31 |
| Medical Device Problem Codes |
Gradient Increase (1270); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
|
| Date of Event |
05/24/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was learned from implant patient registry that a patient with a 31mm 6900ptfx pericardial mitral valve underwent a redo mitral valve replacement procedure after an implant duration of 7 years, 1 month due to unknown reasons.The explanted valve was replaced with a 31mm 11400m valve.The patient was noted to be in recovery post procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: additional manufacturer narrative: updated: b4, b5, g3, g6, h2, h6.
|
| |
|
Event or Problem Description
|
|
It was learned from implant patient registry that a patient with a 31mm 6900ptfx pericardial mitral valve underwent a redo mitral valve replacement procedure after an implant duration of 7 years, 1 month due to mitral stenosis.The patient initially presented with heart failure and shortness of breath.The explanted valve was replaced with a 31mm 11400m valve.The patient was noted to be in stable condition in the icu post procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: additional manufacturer narrative: the device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient-related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction.A definitive root cause cannot be conclusively determined; however, patient factors likely caused or contributed.
|
| |
|
Search Alerts/Recalls
|